SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0897190008318914v1
21/6/420    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Silverberg, D. S.
Right arrow Articles by Schwartz, D.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Role of Correction of Anemia in Patients With Congestive Heart Failure Associated with Chronic Kidney Failure

Donald S. Silverberg, MD

Department of Nephrology, Tel Aviv Medical Center, Tel Aviv, donald{at}netvision.net.ilIsrael,

Dov Wexler, MD

Department of Cardiology and Heart Failure, Tel Aviv Medical Center, Tel Aviv, Israel

Adrian Iaina, MD

Department of Nephrology, Tel Aviv Medical Center, Tel Aviv, Israel

Doron Schwartz, MD

Department of Nephrology, Tel Aviv Medical Center, Tel Aviv, Israel

Patients with congestive heart failure (CHF) who are also anemic have more severe CHF and a higher mortality, morbidity, and hospitalization rate than those who are not anemic. However, it is not known if the anemia is actually contributing to the CHF or if it is merely comorbidity (ie a marker of increased inflammation or chronic kidney disease [CKD]). The only way to demonstrate that anemia is a causative factor is to correct it, independent of other CHF factors. In this paper we review the results of the published papers about correction of anemia in patients with CHF. Taken in sum, these reports show a quite consistent positive effect of erythropoietic stimulating agents (ESAs) along with oral or intravenous (IV) iron or even of IV alone on clinical indicators and clinical outcomes of patients with CHF. More work is needed to clarify the important relationship between anemia, CHF, and CKD.

Key Words: anemia • heart failure • erythropoietin • renal failure • iron

This version was published on December 1, 2008

Journal of Pharmacy Practice, Vol. 21, No. 6, 420-423 (2008)
DOI: 10.1177/0897190008318914


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement